Niva Bupa Health (NIVABUPA) | Stock Overview & Key Data
Niva Bupa Health Performance Comparison
Stock Range
Today's Range
Low: ₹84.87
High: ₹86.99
on August 22, 2025
52 Week Range
Low: ₹68.54
High: ₹109.34
on April 7, 2025
on December 5, 2024
All-Time High: ₹109.34 on December 2, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR155.4B
EPS
0.76
P/E Ratio (TTM)
110.79
Forward P/E
53.40
P/B Ratio
4.67
PEG Ratio
N/A
Div. Yield
N/A
ROE
4.75%
Beta
N/A
Debt to Equity
7.71
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-6.66%
Profit Margin
2.01%
Returns and Earnings
Return on Assets (TTM)
2.19%
Return on Equity (TTM)
4.75%
EBITDA
INR2.7B
Net Income (TTM)
INR1.3B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR35.55
Quarterly Revenue Growth (YoY)
13.60%
Quarterly Earnings Growth (YoY)
16.08%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Niva Bupa Health NIVABUPA | 155.35B Mid-cap | -0.95% | -3.84% | -3.47% | 9.93% | 2.04% | 15.47% | 15.47% | 15.47% |
| Life Insurance LICI | 5.66T Large-cap | -0.12% | -3.26% | 5.13% | 14.66% | -0.81% | -16.23% | 32.67% | 8.84% |
| SBI Life Insurance SBILIFE | 1.86T Large-cap | -0.21% | 2.76% | 5.67% | 25.06% | 32.75% | 3.90% | 41.51% | 118.31% |
| Religare Enterprises RELIGARE | 84.42B Mid-cap | 0.28% | -12.38% | 8.72% | 0.57% | -9.68% | -7.96% | 91.09% | 503.37% |
| HDFC Life Insurance HDFCLIFE | 1.71T Large-cap | -0.28% | 3.33% | 4.35% | 27.84% | 27.79% | 8.20% | 39.13% | 33.83% |
| ICICI Prudential ICICIPRULI | 920.34B Large-cap | -1.63% | 0.15% | 1.02% | 10.53% | -5.12% | -14.47% | 5.78% | 38.72% |
Ownership & Short Interest
Insider Ownership
75.84%
Institutional Ownership
13.85%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
3M
Average 90-Day Volume
4M
Niva Bupa Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Niva Bupa Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NIVABUPA's 52-week high and low?
- In the last 52 weeks, Niva Bupa Health reached a high of ₹109.34 (on December 5, 2024) and a low of ₹68.54 (on April 7, 2025).
- What is the market cap and P/E ratio for NIVABUPA?
- Curious about Niva Bupa Health's size and valuation? Its market capitalization stands at 155.35B. When it comes to valuation, the P/E ratio (trailing twelve months) is 110.79, and the forward P/E (looking ahead) is 53.40.
- Does NIVABUPA pay dividends? If so, what's the yield?
- As for dividends, Niva Bupa Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Niva Bupa Health's main competitors or similar companies to consider before investing?
When looking at Niva Bupa Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Life Insurance
LICI5.66T Financial Services Insurance - Life -16.23% 32.67% SBI Life Insurance
SBILIFE1.86T Financial Services Insurance - Life 3.90% 41.51% Religare Enterprises
RELIGARE84.42B Financial Services Insurance - Life -7.96% 91.09% HDFC Life Insurance
HDFCLIFE1.71T Financial Services Insurance - Life 8.20% 39.13% ICICI Prudential
ICICIPRULI920.34B Financial Services Insurance - Life -14.47% 5.78% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Niva Bupa Health Insurance Company Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Niva Bupa Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.75%, the Debt to Equity ratio from the most recent quarter is 7.71, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for NIVABUPA?
- Looking at Niva Bupa Health's growth, its revenue over the trailing twelve months (TTM) was INR65B. Compared to the same quarter last year (YoY), quarterly revenue grew by 13.60%, and quarterly earnings saw a YoY growth of 16.08%.
- How much of NIVABUPA stock is held by insiders and institutions?
- Wondering who owns Niva Bupa Health stock? Company insiders (like executives and directors) hold about 75.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 13.85%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.